Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3

Sponsor Class

INDUSTRY 2NETWORK 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 5Genitourinary 3Plasma cell 2Sarcoma 1Head & Neck 1

Conditions

Prostatic Neoplasms 3Multiple Myeloma 2Breast Neoplasms 2Patient Compliance 1Pain 1Osteolysis 1Bone Neoplasms 1

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Clodronic Acid × Genitourinary × Clear all
NCT00003232 2020-04-03

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Canadian Cancer Trials Group

Phase 3 Completed
227 enrolled
Genitourinary

Pain, Prostatic Neoplasms

NCT01198457 2012-09-07

BONA

Bayer

Completed
147 enrolled
BreastGenitourinaryPlasma cell

Breast Neoplasms, Multiple Myeloma, Osteolysis, Patient Compliance, Prostatic Neoplasms

NCT00909142 2012-04-06

BICAM

Bayer

Completed
149 enrolled
BreastGenitourinaryPlasma cellSarcoma

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡